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ORIGINAL ARTICLE
The Correlation between Phalangeal Quantitative
Ultrasonography and Dual Energy X-ray
Absorptiometry in Women with Premature
Ovarian Failure
Tandip S Mann*, Alison H McGregor, Rajesh Patel
ABSTRACT: Objectives – With the growing demand for bone densitometry services there is a need for
simple, cost-effective and ideally mobile devices which can identify individuals who are at risk of
osteoporotic fracture. When new devices are evaluated, it is useful to examine the correlation with the
established ‘gold standard’ technique of dual x-ray absorptiometry (DXA). This study examined the
correlation between quantitative ultrasound (QUS) measurements performed at the phalanges and
conventional DXA measurements of the spine and hip in women with premature ovarian failure – a
known risk factor for osteoporosis. Methods - Thirteen white Caucasian women suffering from
premature ovarian failure and 19 age- and sex-matched controls were recruited into the study. DXA
measurements were performed at the spine and hip, followed by quantitative ultrasonography at
phalanges II-Vof the non-dominant hand. Results – Significant correlations were observed between the
bone transit time (BTT) value from the Bone Profiler and bone mineral density measured at the spine
(r=0.66). The spine Z-scores also correlated with many of the ultrasound values (r=0.44 - 0.63).
Significant inverse correlations were observed between BMI, weight and ultrasound parameters (r = -
0.48 to -0.78). Conclusion – We have reported moderate but significant correlations between
phalangeal QUS and DXAparameters. The strongest correlation was observed between BTT and spine
BMD, as well as between the Z-scores from the two devices. QUS parameters also demonstrated an
inverse correlation with weight and BMI.
KEYWORDS: Bone mineral density, osteoporosis, premature ovarian failure, DXA, quantitative
ultrasound.
INTRODUCTION
In many developed countries, osteoporosis is now
recognised as one of the most serious problems in
public health [1-3]. For a 50-year-old white woman, the
life-time risk of suffering a fragility fracture is
estimated to be 30-40%, which compares with the
figures for breast cancer and cardiovascular disease of
9-12% and 30-40% respectively [3]. The increased
recognition of the impact of osteoporosis on the lives of
elderly people and the consequent costs of healthcare
has led to the development of a variety of new
treatments for preventing fractures [4-7]. Scans to
measure bone mineral density (BMD) using the
technique of dual x-ray absorptiometry (DXA) are
widely believed to be the most effective way of
identifying patients at risk of fracture and targeting
these treatments appropriately [8,9]. Conventionally,
the hip and spine are regarded as the most important
measurement sites because fractures at these sites have
the greatest impact on quality of life, morbidity and
mortality of patients.
An individual’s BMD undergoes progressive changes
throughout life. There is rapid skeletal growth until
peak bone mass (PBM) is reached at around age 30
[10], after which there is minimal change until the
menopause in women. Following menopause, there is
an approximately linear loss of BMD with increasing
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age [11]. PBM occurs in the third decade of life, but an
inadequate nutritional intake of calcium [12] can
prevent optimum peak bone mass being achieved. Low
levels of physical activity during puberty can also lend
to suboptimal bone density in later life [13]. Certain
medical conditions and therapies can also affect bone
metabolism and thus adversely affect BMD [14]. Long-
term corticosteroid use is one such example, causing
changes to trabecular bone structure, as well as reducing
BMD [15]. Other factors known to compromise BMD
include a previous atraumatic fracture or maternal hip
fracture, a previous report of X-ray osteopenia, a
positive family history of osteoporosis [16], a body
mass index (BMI) of less than 19kg/m2, smoking and
suffering from rheumatoid arthritis [17]. Sex hormone
deficiency, most notably oestrogen in females, is a well
established contributor to the pathogenesis of
osteoporosis [18]. Menopause results in oestrogen
deficiency, which stimulates bone resorption [19] and is
associated with substantial bone loss continuing into old
age [20]. The mean age at menopause is around 51
years [21]. However, approximately 1% of women
develop premature ovarian failure (POF) and go
through an early menopause by the age of 40 [22].
Although POF patients commonly receive hormone
replacement therapy (HRT), their BMD remains
significantly lower than that of age-matched controls.
POF thus remains one of the major risk factors for
osteoporosis in women.
With such a variety of risk factors for a reduced BMD
and osteoporosis, there is a need to identify patients
who are at increased risk of sustaining fractures [23].
The Royal College of Physicians in the United
Kingdom have issued guidelines for referring patients
for bone densitometry investigations based on clinical
risk factors [8]. Similar guidelines have also been
published by the European Foundation of Osteoporosis
and Bone Disease [3], the National Osteoporosis
Foundation [24] and the International Society for
Clinical Densitometry [25]. All of the aforementioned
guidelines include early menopause as a recognised risk
factor for osteoporosis and as a basis to refer patients for
a bone density examination.
The most widely accepted method of performing
BMD scans to establish a diagnosis of osteoporosis is
the DXAtechnique. DXAinvolves scanning the lumbar
spine and hip, measurement sites chosen because they
are the most prone to osteoporotic fractures. However,
DXA scanners are relatively expensive pieces of
equipment and their availability is generally restricted
to major hospitals. If the diagnostic benefits of bone
densitometry are to be fully realised, smaller, cheaper
devices are required. One possibility is the introduction
of small DXA scanners designed to scan only the
forearm. This technique is referred to as peripheral
DXA (pDXA). Another peripheral technique is
quantitative ultrasound (QUS). Measurements of
broadband ultrasonic attenuation (BUA) in the
calcaneus can discriminate elderly women with hip
fractures and there is a consensus that QUS has a
potentially valuable role to assess fracture risk. The
attraction to QUS devices is that as well as being cheap
and portable, they do not use ionising radiation.
Since fractures may be present or absent in patients
with similar BMD, bone strength cannot depend
exclusively on bone density, but also on bone
architecture [26]. Use of ultrasound in fracture risk
assessment is thus advantageous as it seems to provide
structural information, e.g. data on trabecular
orientation [27], and can also reflect the mechanical
properties of bone [28] in addition to estimation of its
density. The calcaneus is an easily accessible, weight-
bearing site, rich in trabecular bone and has been the
most extensively studied site with QUS devices [29].
QUS measurements at this site have shown the ability to
detect changes associated with age and menopause
[26,30]. Measurements have also demonstrated the
ability to differentiate healthy subjects from those with
fractures [30,31] and also identifying those who are at
an increased risk of fracture [32,33]. However,
calcaneal QUS measurements can be unreliable in
patients with ankle oedema. Variations in temperature
(both ambient and of the patient’s limb) are also
believed to have an adverse effect on measurements
[34].
An alternative, non-weight-bearing site for the
assessment of bone mass using QUS is at the phalanges.
The phalanges are composed of predominantly cortical
bone and the regions of interest are easily accessible.
The DBM Sonic Bone Profiler (IGEA, Italy) has been
designed to transmit a single ultrasound burst through
the distal metaphyses of the proximal phalanges. Bone
resorption results in enlargement of the medullary canal
and other structural changes, decreasing the ultrasound
velocity and altering the characteristics of the signal
arriving at the receiver probe [35]. The hand is very
sensitive to these changes and is thus ideal for such
assessment [36]. Previous studies using the DBM Sonic
device have reported good precision with a coefficient
of variation of 0.34% [37]. There is also evidence
suggesting that phalangeal QUS measurements may be
more sensitive than calcaneal measurements in
identifying trends due to ageing and menopause [38].
The purpose of the present study was to examine the
correlation between QUS parameters as measured at the
proximal phalanges using the DBM Sonic Bone Profiler
and conventional DXA measurements of BMD at the
spine and hip in Caucasian women with POF. The study134 McGill Journal of Medicine 2008
population was readily available to us from a local
menopause clinic and hence women with POF were
chosen as a specific group in which to assess the
correlation. It was not the aim of the present study to
determine the fracture discrimination capability of the
DBM Sonic device.
METHODS
Study Population
Thirteen Caucasian women (mean age 35.7 yrs, range
30.5 – 40.6 yrs), suffering from POF, were recruited
from the menopause clinic at Chelsea and Westminster
Hospital (London, UK). The control group consisted of
19 age-matched healthy Caucasian women (mean age
32.9 yrs, range 20.4 – 40.1 yrs) and were recruited with
advertisements placed around the hospital sites. The
study was approved by the Charing Cross Hospital
Research Ethics Committee and all participants gave
written informed consent.
Health assessment was carried out using a detailed
questionnaire which included questions relating to
known risk factors for osteoporosis, detailed medical
history of POF, and use of HRT. Women on HRT were
not excluded from the study. However, those with
known risk factors for osteoporosis were excluded.
These included women with a previous atraumatic
fracture, and those on therapies or with conditions
known to affect BMD (including thyroid conditions,
malabsorption and use of corticosteroids).
Dual X-ray Absorptiometery
BMD was measured with a Lunar Prodigy (GE
Healthcare, Madison, WI) DXAscanner. Measurements
were performed at the lumbar spine (L1-L4), hip (total
and neck of femur). In addition to recording BMD at
these sites, we also recorded the T-score (a measure of
how a subjects BMD value compares to those of a
normal young adult at PBM – defined in terms of the
standard deviation of young normal subjects) and Z-
score (a measure of how a subjects BMD compares to
an age-matched population – defined in terms of the
standard deviation of the age-matched population).
BMD measurement of the spine could not be obtained
in one subject due to a navel ring, which could not be
removed.
QUS
QUS measurements were performed on all subjects
using the DBM Sonic Bone Profiler (IGEA, Carpi,
Italy). A calliper was used to position the two probes
(transmitter and receiver) laterally on either side of the
metaphysis of the proximal phalanx, with ultrasound gel
to achieve coupling. An ultrasound signal of 1.2MHz
frequency is transmitted through the finger and an
amplitude-dependent speed of sound (AD-SoS)
parameter is generated, which depends on both the
amplitude and the velocity of the signal received. Finger
thickness andAD-SoS measurements were obtained for
digits II-V of the non-dominant hand. Mean AD-SoS
across all four digits was also obtained. Further
measurement parameters included the Ultrasound Bone
Profile Index (UBPI), a number between 0 and 1
describing the fracture risk [51], and the Bone
Transmission Time (BTT) - the interval between the
first received signal and the received signal that is
propagated through soft tissue only [39]. T-scores and
Z-scores based on the AD-SoS values are also
automatically generated.
Duplicate measurements were performed for each
subject to estimate precision, which was expressed as
the coefficient of variation (CV). The mean values of
the two measurements for each parameter were
recorded and used for analysis. Ambient room
temperature was kept constant with an air conditioning
system as previous reports have suggested that QUS
measurements are temperature-dependent [40]. Daily
quality control measurements to ensure consistency of
calibration were performed with a phantom supplied by
the manufacturer.
Statistical Analysis
Data analysis was performed using Microsoft Excel
(Seattle, WA, USA). Student’s t-test was used to
compare differences in demographic variables and in
QUS and DXA parameters between the two groups. P-
values of less than 0.05 were considered to be
statistically significant. Linear regression analysis was
carried out to determine the correlation between QUS
and DXA parameters in (i) patients only (n=13), (ii)
control group only (n=19) (iii) all participating subjects
(n=32). The following comparisons were made: Spine
BMD v AD-SoS; Spine BMD v BTT; Spine BMD v
QUS Z-score; Spine Z-score v AD-SoS; Spine Z-score
v BTT; Spine Z-score v QUS Z-score. The same
correlations were also determined for hip BMD and hip
Z-scores. The correlation of QUS and DXA parameters
with weight and BMI was also examined.
RESULTS
Duplicate QUS measurements with repositioning on
all 32 patients were combined to give short-term
precision (CV%) of 0.37%, 3.36% 1.67% for AD-SoS,
UBPI and BTT respectively.
Table 1 gives a summary of the demographic data,
BMD parameters and QUS parameters for the patient
group and the controls. Student’s t-test showed no
significant differences in any of the demographic or
measurement parameters between the two groups.Correlation between DXA & phalangeal ultrasound in premature ovarian failure 135 Vol. 11 No. 2
Linear regression analysis was used to establish the
correlation between DXA and QUS parameters. None
of the correlations between UBPI and the DXA
parameters were significant. The correlation between
remaining QUS parameters and spine BMD are shown
in Table 2. A significant correlation (r=0.66) was
observed in POF patients between spine BMD and BTT.
This relationship remained significant (r=0.48) when
all 32 subjects were included in the analysis (Figure 1).
All QUS variables (AD-SoS, BTTand Z-score) showed
significant correlations (r=0.47 to 0.60) with spine Z-
scores (Table 2, Figures 2-4). The T-score is a linear
function ofAD-SoS (for QUS measurements) and BMD
for (DXA measurements). T-score correlations
therefore provide no additional information and were
excluded from the analysis. QUS correlations with
DXA measurements at the hip (total hip and femoral
neck sites) were not significant (Table 2). Normalising
the QUS parameters by age and BMI did not improve
the strength of correlation between any of above
comparisons.
As well as providing the mean AD-SoS values, the
Bone Profiler displays data for the thickness and AD-
SoS for each of the four phalanges measured.
Correlations between the AD-SoS values for individual
fingers and the DXAparameters were again moderate (r
= 0.44 – 0.63) but only significant when compared to
spine Z-scores (Table 3).
Further analysis was carried out to compare QUS
parameters with weight and BMI. Our results show a
All women
n = 32
POF group
n = 13
Control group
n = 19
Age (years)
Height (m)
Weight (kg)
BMI (kg/m2)
34.1 ﾱ 5.1
1.66 ﾱ 0.06
68.3 ﾱ 12.3
24.8 ﾱ 4.6
35.7 ﾱ 3.4
1.65 ﾱ 0.08
68.5 ﾱ 15.7
25.2 ﾱ 5.9
32.9 ﾱ 5.8
1.67 ﾱ 0.05
68.3 ﾱ 9.9
24.5 ﾱ 3.7
QUS DBM Sonic
AD-SoS (m/s)
UBPI
BTT (ﾵs)
2128 ﾱ 74
0.72 ﾱ 0.14
1.54 ﾱ 0.21
2138 ﾱ 85
0.74 ﾱ 0.14
1.53 ﾱ 0.21
2121 ﾱ 67
0.71 ﾱ 0.14
1.54 ﾱ 0.22
DXA Lunar
Spine BMD (g/cm2)
Hip (total) BMD (g/cm2)
Hip (neck) BMD(g/cm2)
1.19 ﾱ 0.11
1.00 ﾱ 0.12
1.03 ﾱ 0.13
1.19 ﾱ 0.11
0.99 ﾱ 0.11
1.02 ﾱ 0.10
1.18 ﾱ 0.11
1.00 ﾱ 0.13
1.04 ﾱ 0.15
Table 1: Demographic, QUS and DXAdata for patient group, control
group and all subjects (mean and standard deviation). Student’s t-tests
show p>0.1 for all parameters
Table 2: Correlation (r-values) between three QUS parameters and
spine BMD shown for all subjects (n=32), POF group (n =13) and
control group (n = 18). Results are also shown for the correlation with
Total Hip BMD and Z-score.*Statistically Significant (p<0.05)
AD-SoS
(m/s)
BTT (ﾵs) Z-score
Spine BMD
(g/cm2)
POF group
Control group
Pooled data
0.12
0.34
0.24
0.66*
0.37
0.48*
0.12
0.34
0.24
Spine Z-scores POF group
Control group
Pooled data
0.43
0.60*
0.51*
0.54
0.43
0.47*
0.43
0.59*
0.51*
Total Hip BMD
(g/cm2)
POF group
Control group
Pooled data
0.08
0.001
0.04
0.52
0.09
0.22
0.08
0.009
0.03
Total Hip
Z-scores
POF group
Control group
Pooled data
0.15
0.12
0.12
0.49
0.12
0.23
0.15
0.13
0.12
Figure 1: Graph showing the positive correlation between the QUS
parameter BTT, and spine BMD for all subjects (n=31; r = 0.48; p =
0.007)
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Figure 2: Graph showing the positive correlation between the QUS
parameterAD-SoS, and spine Z-score for all subjects (n=31; r = 0.51;
p = 0.003).
Figure 3: Graph showing the positive correlation between the QUS
parameter BTT, and spine Z-score for all subjects (n=31; r = 0.47; p =
0.008)
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reasonably strong inverse correlation between all 3
QUS parameters (AD-SoS, UBPI and BTT) and BMI
(Table 4). The strongest correlation was with UBPI in
the POF patient group (r = -0.78) (Figure 5). Similar
inverse correlations were observed (r = -0.48 to -0.76)
between QUS parameters and subjects’ weight. Similar
values were also observed when comparing weight and
BMI with AD-SoS values from individual fingers. The
correlation between height and BMI was also
established for DXAmeasurements at the spine and hip.
Moderate but significant positive correlations were
observed with spine and hip BMD (r = 0.37 – 0.62).
Finally, the correlation ofAD-SoS values between the
digits was established and found to be highly significant
(p<0.0001). The strongest correlation (r=0.96) was
observed between the index and middle fingers (Figure
6). Student’s t-test demonstrated significant differences
inAD-SoS and thickness values between fingers. These
observations were similar in the patient group and in the
controls. The AD-SoS values were greatest in phalanx
III, followed by IV, II and V (p < 0.02).
DISCUSSION
Because of the growing demand for bone
densitometry services, there is a need for cheap, safe
and portable devices that can be used in a primary care
setting to assess BMD and fracture risk. The ability of
a device to independently assess fracture risk is best
established through prospective fracture studies which
can be expensive and time consuming. When
evaluating new bone density scanners it is of interest to
examine the correlation with DXA measurements at the
spine and hip – the established ‘gold standard’ bone
density measurements. In this study, we investigated
the correlation between QUS parameters obtained using
the DBM Sonic Bone Profiler and spine and hip
Table 3: Correlation (r-values) between individual phalanx AD-SoS
values and the spine Z-score measurements from the DXA for all
subjects (n=31), POF group (n =13) and the control group (n = 18)
*Statistically Significant (p<0.05)
Phalanx II
AD-SoS (m/s)
Phalanx III
AD-SoS (m/s)
Phalanx IV
AD-SoS (m/s)
Phalanx V
AD-SoS (m/s)
Spine
Z-score
POF group
Control group
Pooled data
0.38
0.59*
0.49*
0.30
0.63*
0.47*
0.53
0.39
0.44*
0.44
0.50*
0.47*
AD-SoS
(m/s)
Z-score UBPI
BMI
(kg/m2)
POF group
Control group
Pooled data
-0.69*
-0.48*
-0.58*
-0.69*
-0.48*
-0.58*
-0.78*
-0.25
-0.49*
Weight POF group
Control group
Pooled data
-0.49
-0.48*
-0.48*
-0.50
-0.48*
-0.48*
-0.76*
-0.25
-0.57*
Table 4: Correlation (r values) between three QUS parameters and
BMI; split by POF group (n =13), control group (n = 19) and the
pooled data (n = 32). Correlations are also shown for weight.
*Statistically Significant (p<0.05)
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Figure 4: Graph showing the positive correlation between the QUS
Z-score and spine Z-score for all subjects (n=31; r = 0.51; p = 0.003).
Figure 5: Graph showing the inverse correlation between BMI and
the QUS parameter UBPI for the POF group (n=13; r = -0.78; p =
0.002)
Figure 6: Graph showing the positive correlation between AD-SoS
measurements obtained from the index (phalanx II) and the middle
(phalanx III) fingers, for all subjects (n=32; r = -0.96; p < 0.0001).
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measurements acquired on a Lunar Prodigy system.
The precision analysis of our QUS measurements
returned CV% values of 0.37 - 3.36% for the various
parameters. The AD-SoS precision compare favourably
with previously reported results [41,42]. The precision
for the Prodigy DXAdevice has been previously quoted
as 1.0% for the spine (L1-L4), 0.9% for hip (total) and
1.5% for femoral neck [43].
Linear regression analysis between DXA and QUS
parameters showed a significant correlation of 0.66
(p=0.01) between the BTT value and spine BMD in
women with POF, although this was not the case for
other QUS parameters. BTT is a measure of the time
delay between the two signals arriving at the receiver
probe, with one having passed through bone and the
other through the soft tissue phase. The significant
correlation observed in our study could indicate that an
improved bone structure at the phalanx correlates with
higher bone density at the spine, and thus allows a more
rapid transmission of the ultrasound signal through
bone compared to soft tissue. Although much of the
literature currently focuses on the AD-SoS values
provided by the QUS device, Montagnani et al [44]
have presented data highlighting the importance of BTT
as the parameter most comparable to DXA and with the
greatest ability to predict osteoporotic fractures.
Significant correlations of r=0.5 to 0.6 were observed
between spine Z-scores and AD-SoS, as well as with
BTT. QUS and DXA Z-scores showed a moderate
correlation when the data from patients and controls
was pooled (r=0.51). Although Z-scores are not used in
the diagnosis of osteoporosis our results suggest that
this relationship between Z-scores merits further
investigation. If QUS Z-scores can predict DXA Z-
scores, it may suggest a role for QUS measurements as
a screening tool. It has previously been suggested that
phalangeal QUS Z-scores may be a useful tool in the
screening of bone disturbances in young patients with
type I diabetes mellitus [45]. It is possible that
phalangeal QUS may also have a role in other disease
states affecting bone.
Regression analysis demonstrated thatAD-SoS, UBPI
and QUS Z-score parameters are all inversely related
with both BMI and weight. Although the Bone Profiler
accounts for soft tissue content, weak but significant
correlations (r = -0.30 to -0.32) between AD-SoS and
BMI have been reported previously [41,46].
Interestingly, BTT does not show a similar correlation
but was the only QUS parameter to show a positive
correlation with height in the POF group. A similarly
significant correlation was seen between spine BMD
and height (r = 0.56), which strengthens the argument
for further research into the potential value of BTT as a
predictor of spine BMD. Currently however, the
association between QUS and BMI remains unclear
with some showing evidence of a significant correlation
[47,48], whilst other data remains inconclusive [49].
Alenfeld et al. [48] postulate QUS may depend on body
weight and BMI as the soft tissue surrounding the
phalanges influences both acoustical contact and
velocity.
Repeated student’s t-test analyses for the differences
in mean thickness between phalanges II to V showed a
significant, progressive increase in width from index to
small fingers. However, the mean AD-SoS values were
significantly greater in the middle finger, followed by
the ring, index and small fingers, implying that the QUS
AD-SoS parameter is indeed not simply a function of
the distance between the probes, but can identify
quantitative differences between the structures of the
digits. The potential of QUS measurement to reflect
bone structure, as well as bone density, has in fact been
one of the driving forces for QUS densitometry. QUS
measurements may have a role in assessing fracture risk
in patients on corticosteroids for example [15], which
are known to affect the structure of trabecular bone and
have a detrimental effect ‘over and beyond’ that
reflected in a DXA measurement of low bone mass
alone [50].
Analysis of the collected data has shown significant
correlations between a number of QUS and DXAdevice
parameters, as well as upon comparison with
demographics. Perhaps the most promising of these is
the correlation of spinal BMD with BTT and, with an r2
value of 0.44 in the POF group, offers the best
predictive ability of BMD compared to the other QUS
parameters.
However, other studies have highlighted the use of
alternative QUS parameters for the estimation of BMD.
Alexandersen et al [26] demonstrated weak but
significant correlations between AD-SoS and BMD at
the spine and hip (femoral neck) (r = 0.21 for both
sites), whereas Wuster et al [51] obtained higher
correlations (r = 0.46 and r=0.36 spine and hip BMD,
respectively). The lack of concordance with our study
may lie in the differences between populations from
Denmark, Scandinavia and the UK, respectively.
Furthermore, the Bone Profiler is a device with a higher
sensitivity to skeletal changes occurring in the early
postmenopausal period (in the range 50-65), which
encompasses the population used by Wuster et al [51]
and thus providing the strongest correlations. The mean
age in the Alexandersen study [26] was 69.9 years, at
which age postmenopausal changes can still be
identified. However, our study had a mean age for all
subjects of 34.1 years, with one group having been
through an early menopause and the other group acting
as controls. Thus, differences in the population age and138 McGill Journal of Medicine 2008
inconsistencies of menopausal state of the subjects may
account for the discrepancies. Other studies have also
shown negative associations of QUS parameters with
age [52]. However, the unique patient group we selected
has not been assessed by others in this manner. This
adds a confounding factor to our data making
comparison difficult. An unlikely alternative
explanation for the discrepancies between studies is
user-dependence which was highlighted as significant
factor affecting the accuracy of measurements in a study
by Krieg et al [53] who carried out measurements using
the DBM Sonic on over 7000 women.
One advantage of assessing the human phalanges is
their sensitivity to early changes in bone mass [54], and
work originally based on animal studies has supported
the argument that phalangeal ultrasound can identify
architectural characteristics of bone [35]. However,
unlike the calcaneus, phalangeal bone is not subject to
weight-bearing activity and thus provides weaker
correlations compared to peripheral weight-bearing
sites [54]. Furthermore, inaccurate positioning of the
calliper on the phalanx can lead to errors, as the joint
itself has greater trabecular bone content than the
metaphysis [55] and can therefore contribute to operator
errors. QUS values are also dependent on the
temperature of the limb, which can be difficult to
control in variable climatic conditions. However, in the
present study room temperature was controlled using an
air conditioning system. One further source of
measurement error that has been reported is that the
phalangeal joints are common sites for osteoarthritis
[26], which could interfere with QUS measurements.
The stronger correlation of our results occurring
between QUS and DXA at the spine, as opposed to at
the hip, may partly be explained by the fact that
trabecular rich vertebrae are more sensitive in
identifying changes occurring with age or therapy
compared to the hip.
As well as the relatively small sample size, there were
further limitations to our study. HRT is known to
significantly reduce the impact of the menopause on
bone loss [56] but its duration of use in the present study
(4 months to 7 yrs) varied widely between patients.
Uygur et al [22] have suggested that current HRT
regimes, designed for women undergoing natural
menopause, may be inappropriate for some women with
POF and thus cause further variations in the effects of
HRTin POF groups.The use of HRTmay have different
effects on QUS and DXA parameters.
The potential benefits for phalangeal QUS to be
adopted as a screening device could extend beyond its
correlation with DXA. Other studies have shown the
ability of the phalangeal QUS device to identify
changes associated with age and with the menopause,
but also to predict fracture risk [56-59]. Its relatively
low CV% values can also allow frequent monitoring of
bone health. Although QUS cannot provide a direct
measurement of BMD itself, its potential for detecting
structural changes may be more beneficial than
established areal BMD measurements.
Our study suggests that there may be a need to move
away from focusing on the AD-SoS parameter in place
of the BTT, and even a greater role for Z-scores. BTT
has shown stronger correlation with DXA values and
stronger predictive r2 ability compared to other QUS
parameters. Whilst some authors have described a
combination of clinical risk factors and QUS values in
the form of a ‘nomogram’ as the ideal method of
screening for increased fracture risk [60], others believe
the complex soft tissue–bone–ultrasound interactions
and the resultant waveform they produce should be
analysed [51]. In either case, the aim is to identify
patients at risk of fracture before the fracture occurs.
Possible further roles for phalangeal QUS may include
measurements in children on long-term corticosteroids.
All this is only possible through studies such as this
being able to identify and harness the great expectations
with which these devices were introduced, and allow
early preventative interventions to be taken in high-risk
groups.
CONCLUSION
We have reported moderate but significant
correlations between phalangeal QUS and DXA
parameters. The strongest correlation was observed
between BTTand spine BMD, as well as between the Z-
scores from the two devices. QUS parameters also
demonstrated an inverse correlation with weight and
BMI. These correlations were seen within the POF
group, control group and when data for all patients was
pooled. Our data support further studies to evaluate the
ability of phalangeal QUS measurements to
independently assess fracture risk in patients with and
without different risk factors. Such studies will help
establish whether phalangeal QUS can be used as a
screening tool in the primary care setting. Currently, the
best measurement sites for QUS and the ideal
parameters with which to form guidelines still have to
be established.
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